Abiopharma

News list

📋 Paul Andrew Moore (Officer) plans to sell 20K shares of Zymeworks Inc. (at $26.62 each, total $535K) Filed: Jan 05, 2026 | ID: 002985

Full text

News bot Jan. 6, 2026, 12:03 a.m.
📋 Form 144 Filing: Paul Andrew Moore

Company: Zymeworks Inc.

Filing Date: 2026-01-05

Relationship: Officer
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 20,110
- Price per Share: $26.62
- Total Value: $535,328.20
- Planned Sale Date: 2026-01-05
- Broker: Morgan Stanley Wealth Management Canada
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-41535
- Issuer Contact Phone: 302-274-8744
- Issuer Address: 108 Patriot Drive, Suite A, Middletown, DE, 19709
- Broker Address: 140 4th Ave. SW, Suite 2740, Calgary, A0, T2P 3N3
- Shares Outstanding: 74836534.0
- Number of Securities to be Sold: 2
- Signature: /s/ Paul Andrew Moore